Cytochrome P450 gene

Abstract

A gene encoding a cytochrome P450 expressed specifically at initial stages in flower-bud growth and a promoter inducing expression of the gene are provided. The cytochrome P450 gene encodes the amino acid sequences encoded by the sequence having the nucleotide 1 to 1488 or the nucleotide 1 to 1617 in SEQ ID NO. 1, and the promoter consists of the base sequence within the nucleotide 1 to 1041 in SEQ ID NO. 4 that is necessary for the promoter activity.

Description

FIELD OF THE INVENTION

The present invention relates to plant-derived novel cytochrome P450 genes. The present invention further relates to a cytochrome P450-derived promoter which functions at initial stages of flower-bud formation.

BACKGROUND OF THE INVENTION

Flower buds are formed in a period when higher plants convert their growth from vegetative growth to reproductive growth. In this period, many genes express as the functions and forms of the plants change. It is therefore of significant importance to obtain a gene expressed specifically at initial stages of flower-bud formation and its promoter to provide a means for clarifying the mechanism of reproductive growth and for genetically engineering plants in their reproductive growth period.

However, the mechanism of flower-bud formation has not been fully clarified, and, in particular, no gene that is involved in flower-bud formation or promoter that induces its expression are known.

On the other hand, cytochrome P450 in higher plants is known as a gene which is involved in 1. secondary metabolism of flavonoids and alkaloids, and 2. metabolism of chemicals such as herbicides. Examples of cytochrome P450 involved in the secondary metabolism include cDNA for cinnamate 4-hydroxylase, flavonoid-3'-5'-hydroxylase, jasmonate synthase, and salicylate hydroxylase which have been cloned and are known to be concerned with biophylaxis, and biosynthesis and metabolism of phytohormones and signal substances. It is known that cytochrome P450 genes consist of many groups of genes called superfamily, and it is also known that the homology of amino acid sequences in a family equals to, or more than 40% (Nebert et al. DNA Cell Biol. 10, 1-14, 1991). No presence of a cytochrome P450 that specifically expresses at initial stages of flower-bud growth has been known heretofore.

SUMMARY OF THE INVENTION

The present invention provides a cytochrome P450 expressed specifically at initial stages of flower-bud growth, a gene encoding the cytochrome P450, and a promoter which induces expression of the gene.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a photograph in place of a drawing showing the stages of flower-bud growth.

FIG. 2 shows a Northern blot analysis illustrating expression of M15 gene in each stage of the growth of flower-buds.

FIG. 3 shows a Northern blot analysis illustrating expression of K40 gene in each stage of the growth of flower-buds.

DETAILED DESCRIPTION OF THE INVENTION

The inventors found in studies on the mechanism of flower-bud formation that there are some cytochrome P450 enzymes in petunia that express specifically at the initial stages of flower-bud formation.

The gene of the present invention is a cytochrome P450 gene which expresses at the initial stages of flower-bud formation and that is obtained by cloning using Primer 1 (5'-AAAGAAACATTTCGAAAGCACCC), SEQ ID NO:5, and/or Primer 2 (5'-AAATTCTTCGTCCAGCACCAAATGG) SEQ ID NO:6. An example of the gene of the present invention is a cytochrome P450 gene encoding amino acid sequences encoded by the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1. Another example of the gene of the present invention is a cytochrome P450 gene encoding amino acid sequences encoded by the sequence having the nucleotide 1 to 1617 in SEQ ID NO: 3. The gene is a novel gene which belongs to a new family because its amino acid sequence has a 40% or lower sequence homology with amino acid sequences of known cytochrome P450, because its nucleotide sequence is different from the nucleotide sequences of any known cytochrome P450 genes, and because the site and time of its expression is specific.

The gene of the present invention is readily obtained by those skilled in the art according to the disclosure of the present specification. Leaves or flower buds of petunia (preferably those in the initial stage of growth) may be used as materials for isolation of the gene. For instance, following the procedures described in examples below, mRNA is purified at first from flower buds in the initial stage of growth, and single stranded cDNA is prepared using a reverse transcriptase. Primers for PCR are synthesized based on the amino acid sequences in the vicinity of the heme binding region in known cytochrome P450 (D. R. Nelson, Cytochrom P450, 2nd ed., p575-606, 1995). PCR was performed using the single strand cDNA as a template. The resulting PCR products were sequenced at random to provide a cDNA clone containing a partial nucleotide sequence of the cytochrome P450 (e.g. M15 and K40 in the examples below). A Northern blot analysis was carried out using the cDNA clone as a probe to confirm that the gene contained in the clone is most strongly expressed in initial stages of flower-bud growth. mRNA is purified from tissues in initial stages of flower-bud growth to construct a cDNA library. Screening the cDNA library with the previously acquired cDNA clone containing a partial nucleotide sequence of the cytochrome P450 can provide a full-length cDNA clone (e.g. IMT-1 and IMT-2 in the examples below).

The gene can be confirmed to be a cytochrome P450 gene by examining its sequence homology with known cytochrome P450 genes by comparing their nucleotide sequences, or by expressing the gene with a suitable expression vector in a suitable host, for example, yeast, then measuring the expressed protein with a reduced-type spectrum, a spectrum in the presence of carbon monoxide (Hideo Okawa, Saibo-Kogaku, 6, 72-78, 1987).

The so-called reverse genetic methods, such as 1. introducing to a plant a binary vector which transcripts a gene in an antisense direction to inhibit expression of the gene and examine the phenotype of the plant, or 2. introducing to a plant a binary vector which transcripts a gene in a sense direction to excessively express the gene and examine the phenotype of the plant are widely used to investigate the function of the gene or the activity of the enzyme encoded by the gene. For example, the resulting IMT-1 gene or IMT-2 gene may be inserted downstream of 35S promoter in a sense or antisense direction into a vector to create a binary vector, and the binary vector may be introduced into Petunia hybrida (Surfinia purple, Suntory Ltd.). Transformation of petunia is easy, and is a widely accepted practice.

Alternatively, the use of Petunia hybrida containing transposon dTphl provides a plant having an intended gene (e.g., IMT-1 or IMT-2) destroyed by transposon. An analysis of its phenotype allows us to know the function of the gene and the activity of the enzyme encoded by the gene (Koes, et al. Proceedings of the 4th International Congress of Plant Molecular Biology, 2071, 1994).

At this point in time, the mechanism of the gene of the present invention to be expressed specifically at initial stages in flower-bud formation has not been fully clarified. However, it is presumed that a promoter naturally associating with the cytochrome P450 gene of the present invention may have a nature whereby it specifically induces expression at initial stages in flower-bud formation.

Consequently, the present invention also provides a promoter which naturally associates with the cytochrome P450 gene described above. The promoter is contained in the nucleotide 1 to 452 in SEQ ID NO: 2 or in the nucleotide 1 to 1041 in SEQ ID NO: 4. It may be readily understood that the least necessary region as a promoter is somewhat shorter than this. A promoter modified by insertion, substitution or deletion may have the substantially same promoter activity. Such modification can be made, for example, by site specific mutagenesis or suitable restriction enzyme digestion. Thus, the present invention also includes sequences made by modifying the nucleotide 1 to 452 in SEQ ID NO: 2 or modifying the nucleotide 1 to 1041 in SEQ ID NO: 4 with one or more insertion, substitution and/or deletion, as far as they have the promoter activity.

The promoter of the present invention is isolated generally together with the above-mentioned cytochrome P450 gene. For instance, the promoter can be obtained by cloning promoter sequences related to gene regulation of plasmids (e.g. IMT-1 or IMT-2) containing a full-length cytochrome P450 gene through the inverse PCR method.

It was found that the resulting cytochrome P450 genes belong to new families. This invention clarifies the mechanism of flower-bud growth and enables the application of the cloned gene and its promoter in controlling flowering.

In other words, the genes of the present invention are expected to affect the flowering time, the shape of a flower and so on in various ways by introducing the gene to an ornamental plant, because the genes express specifically at initial stages of flower-bud formation. The genes are introduced preferably functionally combined with the promoters of the present invention, but it is also possible to use another promoter or to use in combination other elements to control the expression as needed. Examples of the ornamental plant include rose, chrysanthemum, carnation, gerbera, petunia, torenia and verbena. The genes of the present invention are further expected to be used to preferably affect the quantity and time of harvesting crops by affecting the flowering of cultivated plants such as grains and fructificative plants. Examples of such plants include rice, wheat, barley, tomato and apple.

It is believed to be possible to introduce the promoters of the present invention which are functionally combined with any desired genes into a plant and to express the genes at initial stages of flower-bud formation in a time-specific manner. Thus, it is possible to introduce the promoter into the ornamental plants and cultured plants such as those described above combined with various genes to affect, for example, color, size, shape, flowering time, flowering inhibition, etc.

The genes can be introduced into a plant by transforming plant cells with a conventional method, e.g. a method using Agrobacterium tumefaciens. The plant cells containing the introduced genes can be selected using a suitable marker when the cells are transformed. The cells confirmed to have the intended gene introduced can be regenerated into plants. Methods are widely known for selecting plant strains which stably maintain the genotype of the introduced gene. See for example, S. C. Deroles, et al., Biotechnology of Ornamental Plants, p87-119, 1997, which describes these techniques.

Cytochromes P450, which express in initial stages in flower-bud formation like cytochromes P450 of the present invention and which have slightly different amino acid sequences or nucleotide sequences, may exist in plants other than petunia. These genes encoding cytochromes P450 can be isolated from plants by the methods described above. More readily, the genes may be isolated by creating cDNA libraries from mRNA extracted from flower buds of respective plants and screening by general methods using as a probe the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1 or a partial sequence consisting of at least 10 to 15 bases selected as needed therefrom. Therefore, the genes and promoters of the present invention include genes encoding the cytochrome P450 which hybridizes with the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1, the nucleotide 1-1617 in SEQ ID NO: 3, or a partial sequence consisting of at least 10 to 15 bases selected as needed therefrom and which express at initial stages in flower-bud formation in plants. Such hybridization can be carried out e.g. under stringent conditions including washing conditions of 6.times. SSC at 50.degree. C.

The present invention further relates to cytochrome P450 which has the amino acid sequence of the amino acid sequence 1 to 496 in SEQ ID NO: 1. The protein can be extracted from petunia or other plants' flower buds at initial stages of formation. It is also possible to obtain the protein by inserting the gene of the present invention into a suitable expression vector, transforming a suitable host such as E. coli with the vector, culturing the transformed host, and purifying the protein from the cells or extracts. The purified protein can be used for flower-bud formation and controlling the form of flowers, etc.

The present invention provides a novel cytochrome P450 gene as well as a promoter thereof. The present invention has further enabled application of the cytochrome P450 gene and the promoter thereof for controlling plant flowering.

The invention will be described more specifically by following examples, which are not intended to limit the scope of the invention.

EXAMPLE 1

Purification of mRNA

Seeds of Petunia hybrida Vilm.TM. (Sakata Inx Corp.) were sown on a vermiculite soil, and were budded and grown at 25.degree. C. under 12-hour light and 12-hour dark conditions. After 100 days, flower-buds were sampled at different five stages of growth (see FIG. 1). mRNA was purified from 0.1 g of flower buds in each stage. QuickPrep Micro mRNA Purification Kit.TM. (Pharmacia) was used to purify mRNA following the manufacturer's recommended procedures.

EXAMPLE 2

Synthesis of Single Strand cDNA

Single strand cDNA was synthesized using as templates about 100 ng of the mRNA from each stage of flower buds in Example 1. First-strand CDNA Synthesis Kit.TM. (Pharmacia) was used to synthesize cDNA following the manufacturer's recommended procedures.

EXAMPLE 3

Synthesis of Primers for PCR and the PCR Conduct

First, Primers 1 and 2 were synthesized as primers for PCR. Recognition sites for restriction endonucleases were inserted to respective primers. The underlined show the recognition sites. The recognition sites are not limited to those shown here but use of other suitable recognition sites is allowed as needed.

SEQ ID NO: 7Primer 1' ; 5' -ATGAATTCAAAGAAACATTTCGAAAGCACCC, EcoRI SEQ ID NO: 8Primer 2'; 5' -ATAAGCTTAAATTCTTCGTCCAGCACCAAATGG, HindIII

Next, PCR was conducted. The reaction was conducted in 50 .mu.l of a reaction fluid containing 0.14 pg/ml of the template single stranded cDNA (a mixture of those from stages 1 to 5) given in Example 2, 10 pmol of Primer 1', 10 pmol of Primer 2', 0.04 mM dNTP, 2.5 mM magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/.mu.l of TaqDNA polimerase (Toyobo Co., Ltd.) The reaction mixture was maintained at 94.degree. C. for 5 minutes, then were cycled 30 times between 94.degree. C. for 1 minute, 40.degree. C. for 1 minute and 72.degree. C. for 3 minutes. Then it was kept at 4.degree. C.

The PCR products were separated by electrophoresis on 2% agarose gel, then DNA fragments of about 250 bp were collected, cleaved with EcoRI and HindIII, then were cloned into the EcoRI site and HindIII site of the pBluescript SK (+) (Stratagene) to introduce into E. coli JM109.

EXAMPLE 4

Analysis of PCR Products

The E. coli JM109 prepared in Example 3 was transformed to give colonies, from which 40 colonies were picked out at random and cultured separately. Plasmid DNA was purified from each culture fluid, and the nucleotide sequence of the DNA was determined at random. This resulted in a clone (M15) which has a partial sequence of the cDNA of cytochrome P450.

EXAMPLE 5

Northern blot Analysis of Expression of M15 Gene

Expression of M15 gene in each stage of flower-buds (FIG. 1) was detected using .sup.32 P-labelled EcoRI-HindIII fragments of the M15 clone as a DNA probe. 0.3 .mu.g of mRNA was used for the analysis. FIG. 2 shows the results. It was demonstrated from FIG. 2 that the maximum expression was obtained in stage 1.

EXAMPLE 6

Cloning CDNA for Cytochrome P450 expressed in Flower Buds

A cDNA library was constructed from the mRNA which was expressed at the stage 1 in the flower-bud growth. The library was constructed using ZAP-cDNA Synthesis Kit.TM. (Stratagene) following the manufacturer's recommended procedures. The Gigapack II Plus.TM. (Stratagene) was used for packaging.

About 300,000 cDNA clones were screened using .sup.32 P-labelled EcoRI-HindIII fragments of the M15 clone as a probe. Seven positive clones were selected. One clone that has the longest insert fragment (hereinafter referred to as IMT-1) was selected and was subjected to sequence analysis of cDNA. This resulted in cDNA encoding a novel full-length cytochrome P450 (SEQ ID NO.1). It was found that the amino acid sequence of the cytochrome P450 has 37% homology with the amino acid sequence of petunia flavonoid-3'-5'-hydroxylase.

EXAMPLE 7

Preparation of Template Genome DNA for Inverse PCR (IPCR)

Chromosome DNA was prepared from 0.5 g of petunia leaves using ISOPLANT.TM. (Nippon Gene). After completely digesting 1 .mu.g of the chromosome DNA with HincII, a self ligation reaction was carried out using T4 DNA ligase to produce template genome DNA for IPCR.

EXAMPLE 8

Inverse PCR (IPCR)

First, four different primers for IPCR were synthesized:

A primer: 5'-AACTAAAATCAAGACAAGTAGTAATCCACC-3'(SEQ ID NO:9); B primer: 5'-GTTGCTTATTGCTAGGTAACGAATACTTG-3'(SEQ ID NO:10); C primer: 5'-ACTCCCCTGCCCTTAATTGGTAATTTACAT-3'(SEQ ID NO:11); and D primer: 5'-AACACTCTTGGTGCTCAACCCCATCAGTCC-3'(SEQ ID NO:12). All the primers are positioned in the vicinity of the 5' end of IMT-1.

Next, PCR amplification was performed twice. The first PCR amplification was conducted in 50 .mu.l of a reaction mixture. The reaction mixture contained 10 ng/.mu.l of the template genome for IPCR obtained in Example 7 as well as 10 pmol of B primer, 10 pmol of C primer, 0.04 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/.mu.l of TaqDNA polimerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94.degree. C. for 5 minutes, then were cycled 30 times between 94.degree. C. for 1 minute, 55.degree. C. for 2 minutes and 72.degree. C. for 3 minutes. Then it was kept at 4.degree. C.

The second PCR amplification was conducted in 50 .mu.l of a reaction mixture. The reaction mixture contained 0.1 ng/.mu.l of the product from the first IPCR, 10 pmol of A primer, 10 pmol of D primer, 0.04 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/.mu.l of TaqDNA polimerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94.degree. C. for 5 minutes, then were cycled 30 times between 94.degree. C. for 1 minute, 55.degree. C. for 2 minutes and 72.degree. C. for 3 minutes. Then it was kept at 4.degree. C.

EXAMPLE 9

Cloning IPCR Products and DNA Sequence Determination

The products from the second IPCR were separated on a 0.7% agarose gel, and a 1.2-kb DNA product was specifically amplified and cloned into pTBlue T-Vector.TM. (Novagen). The plasmid was used to transform E. coli JM109. Seven single clones were cultured and subjected to DNA sequence determination. The sequence of the promoter region of IMT-1 was determined. The gene sequence of the promoter region of IMT-1 is shown in SEQ ID NO: 2 of sequence listing.

EXAMPLE 10

PCR and Analysis of PCR Products

PCR was further conducted using the PCR products obtained in Example 3. One nanogram of the PCR products and 70 pmol of each of primer 2' and primer 3 were reacted in 50 .mu.l of a reaction mixture containing 0.2 mM dNTP, 2.5mM MgCl.sub.2, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/ml of rTaqDNA polimerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94.degree. C. for 3 minutes, then were cycled 40 times between 94.degree. C. for 30 seconds, 50.degree. C. for 30 seconds and 72.degree. C. for 45 seconds. Then it was cooled to 4.degree. C.

The sequence of the primer 3 is shown below:

(SEQ ID NO: 13)Primer 3: 5'-AACTCGAGGGTTACTATATACCAAAAACAC XhoI

The resulting PCR products were separated by electrophoresis on a 2% agarose gel, then the DNA fragments of approximately 200 bp were collected, cloned into the XhoI site and HindIII site of pBluescriptSK+ plasmid vector, and introduced into E. coli JM109.

From the resulting transformed colonies, 22 clones were selected at random and their plasmids were extracted and sequenced. A clone (K40) which has the cDNA sequence of cytochrome P450 was obtained.

EXAMPLE 11

Northern blot Analysis showing Expression of K40 Gene

Expression of K40 gene in each stage of flower-buds (FIG. 1) was detected using .sup.32 P-labelled XhoI-HindIII fragments of the K40 clone as a DNA probe. 0.5 .mu.g of mRNA was used for the analysis. FIG. 3 shows the results. It was demonstrated from FIG. 3 that the maximum expression was obtained in stage 2.

EXAMPLE 12

Cloning cDNA for Cytochrome P450 expressed in Flower Buds

A cDNA library was constructed from the mRNA which expressed at stage 2 in the flower-bud growth. The library was constructed using ZAP-cDNA Synthesis Kit.TM. (Stratagene) following the manufacturer's recommended procedures. The Gigapack II Plus (Stratagene) was used for packaging.

About 500,000 cDNA clones were screened using .sup.32 P-labelled XhoII-HindIII fragments of the K40 clone as a probe. Ninety-three positive clones were selected. One clone that has the longest insert fragment was selected and was subjected to sequence analysis of cDNA. This resulted in cDNA (SEQ ID NO: 3) encoding a novel full-length cytochrome P450 (IMT-2). It was found that the amino acid sequence of the cytochrome P450 has 39% homology with the amino acid sequence of CYP71A1, a molecular species of cytochrome P450 from avocado.

EXAMPLE 13

Preparation of Template Genome DNA for IPCR

Chromosome DNA was prepared from 0.5 g of petunia leaves using ISOPLANT.TM. (Nippon Gene). After completely digesting 1 .mu.g of the DNA with XbaI, self ligation was performed using T4 DNA ligase to produce template genome DNA for IPCR.

EXAMPLE 14

IPCR

In order to obtain the promoter of IMT-2, four different primers were synthesized:

E primer: 5'-AAACAAAGATTGGAGCATAATCGACC-3'(SEQ ID NO:14); F primer: 5'-TAGTTCATTTTTCATTCATCGAGAGG-3'(SEQ ID NO:15); G primer: 5'-TATACGCGAAATAGGACTAGAAGATAATTGG-3'(SEQ ID NO:16); and H primer: 5'-AAACAGAAAATCAATCGACTCCCTCCTGG-3'(SEQ ID NO:17). All the primers are positioned in the vicinity of the 5' end of IMT-2.

Next, PCR amplification was performed twice. The first PCR amplification was conducted in 50 .mu.l of a reaction mixture. The reaction fluid contained 10 ng/.mu.l of the template genome DNA for IPCR, 50 pmol of E primer, 50 pmol of F primer, as well as 0.2 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR.TM. (Expand High Fidelity PCR System.TM., Boehringer Mannheim), and 0.04 unit/.mu.l of enzyme mixes (Expand High Fidelity PCR System, Boehringer Mannheim). The reaction mixture was maintained at 94.degree. C. for 5 minutes, then were cycled 30 times between 94.degree. C. for 1 minute, 60.degree. C. for 1 minute and 72.degree. C. for 3 minutes. Then it was kept at 4.degree. C.

The second PCR amplification was conducted in 50 .mu.l of a reaction mixture. The reaction mixture contained 0.2 ng/.mu.l of the product from the first IPCR, 50 pmol of G primer, 50 pmol of H primer, 0.2 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Expand High Fidelity PCR System.TM., Boehringer Mannheim), and 0.04 unit/.mu.l of enzyme mixes (Expand High Fidelity PCR System.TM., Boehringer Mannheim). The reaction mixes were maintained at 94.degree. C. for 5 minutes, then were cycled 30 times between 94.degree. C. for 1 minute, 60.degree. C. for 1 minute and 72.degree. C. for 3 minutes. Then it was kept at 4.degree. C.

EXAMPLE 15

Cloning IPCR Products and DNA Nucleotide Sequence Determination

The products from the second IPCR were nucleotide separated on a 0.7% agarose gel, and a 1.7-kb DNA product was specifically amplified and cloned into pT7Blue T-Vector.TM. (Novagen). The plasmid was used to transform E. coli JM109. Single clones were cultured and subjected to DNA nucleotide sequence determination. The sequence of the promoter region of IMT-2 was determined. The gene sequence of the promoter region of IMT-2 is shown in SEQ ID NO: 4.

__________________________________________________________________________# SEQUENCE LISTING - - - - (1) GENERAL INFORMATION: - - (iii) NUMBER OF SEQUENCES: 17 - - - - (2) INFORMATION FOR SEQ ID NO:1: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1722 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #1: - - ATG AAT TAT GTA GCA ATT GTA GGT GGA TTA CT - #A CTT GTC TTG ATTTTA 48 Met Asn Tyr Val Ala Ile Val Gly Gly Leu Le - #u Leu Val Leu Ile Leu 1 5 - # 10 - # 15 - - GTT CAA AGT ATT CGT TAC CTA GCA ATA AGC AA - #C AAA TGT CAC AAA AAG 96 Val Gln Ser Ile Arg Tyr Leu Ala Ile Ser As - #n Lys Cys His Lys Lys 20 - # 25 - # 30 - - CTT CCA CCA GGA CCA ACT CCC CTG CCC TTA AT - #T GGT AAT TTA CAT AAC 144 Leu Pro Pro Gly Pro Thr Pro Leu Pro Leu Il - #e Gly Asn Leu His Asn 35 - # 40 - # 45 - - ACT CTT GGT GCT CAA CCC CAT CAG TCC CTT GC - #G AAA CTT GCC AAA AAA 192 Thr Leu Gly Ala Gln Pro His Gln Ser Leu Al - #a Lys Leu Ala Lys Lys 50 - # 55 - # 60 - - TAT GGT CCA ATT ATT AGC CTC AGG TTG GGC CA - #A ATT ACG ACA GTG GTT 240 Tyr Gly Pro Ile Ile Ser Leu Arg Leu Gly Gl - #n Ile Thr Thr Val Val 65 - # 70 - # 75 - # 80 - - ATA TCT TCA CCA ACA ATG GCT AAA GAA GTC TT - #A CAA AAA CAA GAT TTA 288 Ile Ser Ser Pro Thr Met Ala Lys Glu Val Le - #u Gln Lys Gln Asp Leu 85 - # 90 - # 95 - - GCC TTC TCC AGT AGA ACA ATT CCA AAT GCA CT - #C CAT GCT CAT AAT CAT 336 Ala Phe Ser Ser Arg Thr Ile Pro Asn Ala Le - #u His Ala His Asn His 100 - # 105 - # 110 - - TAT CAA TAC TCT GTT GTA TGG CTA CCA GTT GC - #T GCT AGA TGG AGA AGC 384 Tyr Gln Tyr Ser Val Val Trp Leu Pro Val Al - #a Ala Arg Trp Arg Ser 115 - # 120 - # 125 - - CTT CGG AAA ATC TTG AAT TCT AAT ATT TTC TC - #T AGC AAC AGG CTT GAT 432 Leu Arg Lys Ile Leu Asn Ser Asn Ile Phe Se - #r Ser Asn Arg Leu Asp 130 - # 135 - # 140 - - GCA AAT CAG CAT CTC AGG TCC CGA AAG ATA CA - #A GAG TTT ATT GAT TAT 480 Ala Asn Gln His Leu Arg Ser Arg Lys Ile Gl - #n Glu Phe Ile Asp Tyr 145 1 - #50 1 - #55 1 -#60 - - TGC CGA AAG TGT AGC CAA ACA GGG GAG GCA GT - #G AAT ATA GGC CAAGCT 528 Cys Arg Lys Cys Ser Gln Thr Gly Glu Ala Va - #l Asn Ile Gly Gln Ala 165 - # 170 - # 175 - - GCT TTT GAG ACC TCT ATT AAT TTA CTT TCC AA - #T ACT ATT TTC TCC AAG 576 Ala Phe Glu Thr Ser Ile Asn Leu Leu Ser As - #n Thr Ile Phe Ser Lys 180 - # 185 - # 190 - - GAT GTA GTC CAC CCT TAT GCA AAT TCA GAA TT - #C AAG GAT GTT GTT TGG 624 Asp Val Val His Pro Tyr Ala Asn Ser Glu Ph - #e Lys Asp Val Val Trp 195 - # 200 - # 205 - - AAA ATC ATG GAA GAA GCT GGT AAG CCA AAC TT - #G GCT GAT TAT TAC CCA 672 Lys Ile Met Glu Glu Ala Gly Lys Pro Asn Le - #u Ala Asp Tyr Tyr Pro 210 - # 215 - # 220 - - ATC TTG GGA AAG ATT GAT CCT CAA GGG ATA AG - #G CGA CGC GTA GGC AAG 720 Ile Leu Gly Lys Ile Asp Pro Gln Gly Ile Ar - #g Arg Arg Val Gly Lys 225 2 - #30 2 - #35 2 -#40 - - TGT TTT GGT AAG TTG CTT CAG CAG ATT GAG GG - #A TTG ATT GAT CAACGT 768 Cys Phe Gly Lys Leu Leu Gln Gln Ile Glu Gl - #y Leu Ile Asp Gln Arg 245 - # 250 - # 255 - - TTG CAG CAA AGG AAG AAA TTG CAA ACT GGC GA - #T AGT GCT GAT GTT CTT 816 Leu Gln Gln Arg Lys Lys Leu Gln Thr Gly As - #p Ser Ala Asp Val Leu 260 - # 265 - # 270 - - GAT GTT TTG TTA GAT ACT AGC CAA GAA GAT CC - #A CAT GCA ATT GAT AGA 864 Asp Val Leu Leu Asp Thr Ser Gln Glu Asp Pr - #o His Ala Ile Asp Arg 275 - # 280 - # 285 - - AAT CAT ATA GAG CGC TTG TGC ATG GAC CTT TT - #T ATT GCG GGG ACT GAT 912 Asn His Ile Glu Arg Leu Cys Met Asp Leu Ph - #e Ile Ala Gly Thr Asp 290 - # 295 - # 300 - - ACA AGT TCA AAT ACA TTA GAA TGG GCA ATG GT - #T GAG ACC ATG AGG AAA 960 Thr Ser Ser Asn Thr Leu Glu Trp Ala Met Va - #l Glu Thr Met Arg Lys 305 3 - #10 3 - #15 3 -#20 - - CCA TAC ATA ATG AAA AAA GCT AAA AAC GAG CT - #A GCA GAA GTT ATTGGC 1008 Pro Tyr Ile Met Lys Lys Ala Lys Asn Glu Le - #u Ala Glu Val Ile Gly 325 - # 330 - # 335 - - AAA GGC AGC GTA ATA GAA GAA GCT GAT ATT GG - #A CGT CTC CCT TAT TTG 1056 Lys Gly Ser Val Ile Glu Glu Ala Asp Ile Gl - #y Arg Leu Pro Tyr Leu 340 - # 345 - # 350 - - CAG TGC ATT GTT AAA GAA ACC TTA AGA ATA CA - #C CCA CCA GGT CCC TTT 1104 Gln Cys Ile Val Lys Glu Thr Leu Arg Ile Hi - #s Pro Pro Gly Pro Phe 355 - # 360 - # 365 - - TTA ATT CGC AAG GTT GAT CAA GAC GTT GAG GC - #G TGT GGC TAT TTT GTT 1152 Leu Ile Arg Lys Val Asp Gln Asp Val Glu Al - #a Cys Gly Tyr Phe Val 370 - # 375 - # 380 - - CCA AAA GAC TCT CAA GTG TTG GTG CAT ATA TG - #G TCA ATA GGC CGC GAC 1200 Pro Lys Asp Ser Gln Val Leu Val His Ile Tr - #p Ser Ile Gly Arg Asp 385 3 - #90 3 - #95 4 -#00 - - CCA ACT ATA TGG GAG GAT CCT TTG GTA TTT AA - #G CCC GAA AGA TTTTGG 1248 Pro Thr Ile Trp Glu Asp Pro Leu Val Phe Ly - #s Pro Glu Arg Phe Trp 405 - # 410 - # 415 - - GGT ACA AAA ATG GAC GTT CGT GGA CAA GAT TT - #T GAA CTC ATT CCA TTT 1296 Gly Thr Lys Met Asp Val Arg Gly Gln Asp Ph - #e Glu Leu Ile Pro Phe 420 - # 425 - # 430 - - GGT GCC GGA CGA AGA ATT TGC CCG GGA TTA CC - #T TTG GCA ACC AGG ACA 1344 Gly Ala Gly Arg Arg Ile Cys Pro Gly Leu Pr - #o Leu Ala Thr Arg Thr 435 - # 440 - # 445 - - TTA ACT GCA ATG TTG GGT TCA TTG TTG AAT TC - #A TTT GAT TGG AAA GTT 1392 Leu Thr Ala Met Leu Gly Ser Leu Leu Asn Se - #r Phe Asp Trp Lys Val 450 - # 455 - # 460 - - GAA GGC CAT ATT GAA CCA GAA GAT TTG GAT GT - #G GAA GAA AAG TTT GGC 1440 Glu Gly His Ile Glu Pro Glu Asp Leu Asp Va - #l Glu Glu Lys Phe Gly 465 4 - #70 4 - #75 4 -#80 - - ATT ACC CTG GCG AGA TCA CGT TCT TTA CGA GC - #T GTA CCT ATT CCGCTA 1488 Ile Thr Leu Ala Arg Ser Arg Ser Leu Arg Al - #a Val Pro Ile Pro Leu 485 - # 490 - # 495 - - TAAATATCCT CACCCAGATT CGCCATATAC ATTATTGTTG ACAAGATAAC AC -#CGAAAACT 1548 - - GAAGTATTGG GCGTCTTGAT CTTATAACTT TGTCATGAAT AATAGTGTTC CA -#CATGTTAT 1608 - - AGTATATATT TATATTATGA TTTGTTACCA TAATAGTAAA GGTATTATTG TC -#CTTTGCAT 1668 - - ATATTATAAA TAAATGTCAG GAGTTCATAG TTATCAAAAA AAAAAAAAAA AA - #AA 1722 - - - - (2) INFORMATION FOR SEQ ID NO:2: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 452 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #2: - - TTAACCTTAA CGTACACCGG GCCCTCAGCT AGGGGGGGAA AAAAATTTAT TA -#GGAATTTG 60 - - TAGCTCTCCC AATTAAAAAA AAAATTGTTG TTTCCAAAAT ACTTTTTATT TT -#GACCAAAC 120 - - TCTCCAAATT TCCTTAAAAG TGTTTTTCTC AAAGAAAAAA AAAATCCTTA GG -#TTCGGCAA 180 - - AAATTTGGCC AAATAGGCCA TTAGTGAGAC TAACCAAATT AAAGACCAAG TT -#GCAAAAAT 240 - - AGGCCTGGAA CTCACCGATC CCTCTTTTGT CATCAATTGT TATTATGTAA TA -#CCATACAA 300 - - GACTTATTAG GACCTACCGG CTAAGTTCAC TAGACTTGAT CCAAGAATTA GG -#TGCACTAT 360 - - TAATTTCTTT TCCGCCTGTG TACTATTAAT TTTAAATCAG TATTTATATC CC -#TGCCTCAT 420 - - GGCTTGTTCA ACTAGGAAGA AAGAAGTAAA CA - # - # 452 - - - - (2) INFORMATION FOR SEQ ID NO:3: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1761 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #3: - - ATG ATT GAC TTT ACC AAT TAT CTT CTA GTC CT - #A TTT CGC GTA TAT ATC 48 Met Ile Asp Phe Thr Asn Tyr Leu Leu Val Le - #u Phe Arg Val Tyr IlE 1 5 - # 10 - # 15 - - TTT TAT TTG GTC GAT TAT GCT CCA ATC TTT GT - #T TGC GTA TAT CTT GTT 96 Phe Tyr Leu Val Asp Tyr Ala Pro Ile Phe Va - #l Cys Val Tyr Leu Val 20 - # 25 - # 30 - - TCC AAG CTA GTT CAT TTT TCA TTC ATC GAG AG - #G TCC AAA CAG AAA ATC 144 Ser Lys Leu Val His Phe Ser Phe Ile Glu Ar - #g Ser Lys Gln Lys Ile 35 - # 40 - # 45 - - AAT CGA CTC CCT CCT GGT CCA AAA CAG TGG CC - #T ATT GTT GGC AAC CTT 192 Asn Arg Leu Pro Pro Gly Pro Lys Gln Trp Pr - #o Ile Val Gly Asn Leu 50 - # 55 - # 60 - - TTT CAA TTA GGG CAA TTG CCT CAC AGA GAC AT - #G GCT TCA TTT TGT GAT 240 Phe Gln Leu Gly Gln Leu Pro His Arg Asp Me - #t Ala Ser Phe Cys Asp 65 - # 70 - # 75 - # 80 - - AAA TAT GGA CCA TTG GTC TAC CTC CGA CTA GG - #T AAT GTT GAT GCT ATA 288 Lys Tyr Gly Pro Leu Val Tyr Leu Arg Leu Gl - #y Asn Val Asp Ala Ile 85 - # 90 - # 95 - - ACA ACA AAT GAT CCC GAA ATC ATA AGG GAA AT - #A CTT GTA CAA CAA GAC 336 Thr Thr Asn Asp Pro Glu Ile Ile Arg Glu Il - #e Leu Val Gln Gln Asp 100 - # 105 - # 110 - - GAT ATT TTT GCG TCT AGA CCC AGG ACT CTT GC - #T GCC ATA CAT CTA GCT 384 Asp Ile Phe Ala Ser Arg Pro Arg Thr Leu Al - #a Ala Ile His Leu Ala 115 - # 120 - # 125 - - TAT GGT TGT GGA GAT GTA GCA TTG GCT CCC TT - #A GGA CCA AAA TGG AAG 432 Tyr Gly Cys Gly Asp Val Ala Leu Ala Pro Le - #u Gly Pro Lys Trp Lys 130 - # 135 - # 140 - - AGA ATG AGA AGA ATA TGT ATG GAA CAT TTG TT - #G ACA ACT AAA AGG CTC 480 Arg Met Arg Arg Ile Cys Met Glu His Leu Le - #u Thr Thr Lys Arg Leu 145 1 - #50 1 - #55 1 -#60 - - GAG TCC TTT GGA AAG CAT CGG GCA GAT GAA GC - #C CAA AGC CTA GTTGAA 528 Glu Ser Phe Gly Lys His Arg Ala Asp Glu Al - #a Gln Ser Leu Val Glu 165 - # 170 - # 175 - - GAT GTA TGG GCC AAG ACA CAA AAA GGA GAG AC - #A GTG AAC TTA AGG GAT 576 Asp Val Trp Ala Lys Thr Gln Lys Gly Glu Th - #r Val Asn Leu Arg Asp 180 - # 185 - # 190 - - TTA TTA GGG GCT TTT TCA ATG AAC AAT GTA AC - #T AGG ATG TTG TTG GGA 624 Leu Leu Gly Ala Phe Ser Met Asn Asn Val Th - #r Arg Met Leu Leu Gly 195 - # 200 - # 205 - - AAG CAA TTC TTT GGG GCA GAG TCA GCA GGG CC - #A CAA GAA GCA ATG GAA 672 Lys Gln Phe Phe Gly Ala Glu Ser Ala Gly Pr - #o Gln Glu Ala Met Glu 210 - # 215 - # 220 - - TTT ATG CAC ATA ACT CAT GAG TTA TTT TGG CT - #T CTT GGA GTG ATT TAT 720 Phe Met His Ile Thr His Glu Leu Phe Trp Le - #u Leu Gly Val Ile Tyr 225 2 - #30 2 - #35 2 -#40 - - CTG GGT GAC TAT TTA CCT TTA TGG AGG TGG AT - #T GAC CCT CAT GGTTGT 768 Leu Gly Asp Tyr Leu Pro Leu Trp Arg Trp Il - #e Asp Pro His Gly Cys 245 - # 250 - # 255 - - GAG AAG AAA ATG AGG GAA GTG GAG AAA AGG GT - #T GAT GAT TTT CAC ATG 816 Glu Lys Lys Met Arg Glu Val Glu Lys Arg Va - #l Asp Asp Phe His Met 260 - # 265 - # 270 - - AGA ATT ATT GAA GAA CAT AGA AAG AAC GGA AA - #A AAT GTT GAT GAA GGT 864 Arg Ile Ile Glu Glu His Arg Lys Asn Gly Ly - #s Asn Val Asp Glu Gly 275 - # 280 - # 285 - - GAA ATG GAC TTT GTT GAT GTT TTA TTG TCT TT - #G CCA GGT GAA GAT GAA 912 Glu Met Asp Phe Val Asp Val Leu Leu Ser Le - #u Pro Gly Glu Asp Glu 290 - # 295 - # 300 - - GGA GAT GGG AAT GGA AAA CAA CAC ATG GAT GA - #C ACA GAG ATA AAA GCT 960 Gly Asp Gly Asn Gly Lys Gln His Met Asp As - #p Thr Glu Ile Lys Ala 305 3 - #10 3 - #15 3 -#20 - - CTA ATT CAG GAT ATG ATA GCT GCA GCC ACG GA - #T ACA TCT GCT GTCACC 1008 Leu Ile Gln Asp Met Ile Ala Ala Ala Thr As - #p Thr Ser Ala Val Thr 325 - # 330 - # 335 - - AAC GAA TGG CCA ATG GCT GAG GTG ATA AAG CA - #T CCA AAT GTC CTC AAG 1056 Asn Glu Trp Pro Met Ala Glu Val Ile Lys Hi - #s Pro Asn Val Leu Lys 340 - # 345 - # 350 - - AAG ATC CAA GAA GAA CTT GAT ATT GTT GTT GG - #A TCG GAC CGT ATG GTA 1104 Lys Ile Gln Glu Glu Leu Asp Ile Val Val Gl - #y Ser Asp Arg Met Val 355 - # 360 - # 365 - - ACC GAA TCC GAC TTG GTT CAT CTC AAG TAC CT - #T CGT TGT GTA GTA CGT 1152 Thr Glu Ser Asp Leu Val His Leu Lys Tyr Le - #u Arg Cys Val Val Arg 370 - # 375 - # 380 - - GAA ACA TTT CGA ATG CAC CCT GCT GGT CCA TT - #T CTA ATT CCA CAT GAA 1200 Glu Thr Phe Arg Met His Pro Ala Gly Pro Ph - #e Leu Ile Pro His Glu 385 3 - #90 3 - #95 4 -#00 - - TCA ATT CGA GAT ACT AAG ATC AAC GGC TAT TA - #T ATC CCA GCA AAGACA 1248 Ser Ile Arg Asp Thr Lys Ile Asn Gly Tyr Ty - #r Ile Pro Ala Lys Thr 405 - # 410 - # 415 - - CGT GTC TTC ATC AAC ACA CAT GGT CTT GGT AG - #A AAC ACA AAG ATA TGG 1296 Arg Val Phe Ile Asn Thr His Gly Leu Gly Ar - #g Asn Thr Lys Ile Trp 420 - # 425 - # 430 - - GAT AAT ATT GAT GAG TTT AGG CCA GAG AGA CA - #T TTG CCT GCA GAT GAA 1344 Asp Asn Ile Asp Glu Phe Arg Pro Glu Arg Hi - #s Leu Pro Ala Asp Glu 435 - # 440 - # 445 - - TTA AGT AGA GTT GAA ATA AGT CAT GGG GCA GA - #T TTC AAG ATT TTA CCA 1392 Leu Ser Arg Val Glu Ile Ser His Gly Ala As - #p Phe Lys Ile Leu Pro 450 - # 455 - # 460 - - TTT AGT GCT GGA AAA AGG AAG TGT CCT GGT GC - #A CCA TTA GGA GTG AAA 1440 Phe Ser Ala Gly Lys Arg Lys Cys Pro Gly Al - #a Pro Leu Gly Val Lys 465 4 - #70 4 - #75 4 -#80 - - TTG GTA CTT ATG GCT TTG GCT AGA TTG TTC CA - #T TGC TTT GAG TGGAGC 1488 Leu Val Leu Met Ala Leu Ala Arg Leu Phe Hi - #s Cys Phe Glu Trp Ser 485 - # 490 - # 495 - - CCA CCA GAT GGA TTA CGG CCT GAA GAT ATT GA - #C ACA ATT GAG GTT TAC 1536 Pro Pro Asp Gly Leu Arg Pro Glu Asp Ile As - #p Thr Ile Glu Val Tyr 500 - # 505 - # 510 - - GGA ATG ACT ATG CCT AAA GCT AAG CCA TTG AT - #G GCT ATT GCT AGG CCT 1584 Gly Met Thr Met Pro Lys Ala Lys Pro Leu Me - #t Ala Ile Ala Arg Pro 515 - # 520 - # 525 - - CGA CTG CCT GAT CAC CTG TAC CAC TCA ATC AA - #A TGATTTATCA TTTCCTTATA 1637 Arg Leu Pro Asp His Leu Tyr His Ser Ile Ly - #s * 530 - # 535 539 - - CAAATTAAAA GTGTGTTATT AATAACTTTT TTAAGTAGTT GGACCATATA GT -#TATTTGTG 1697 - - TAGACAGATA CTAAAATATG ATACATCTCT TTTTCTGAAT CAATAAAAAA AA -#AAAAAAAA 1757 - - AAAA - # - # - # 1761 - - - - (2) INFORMATION FOR SEQ ID NO:4: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1041 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #4: - - GAAACAGCGC AGATACCAGT GCTGAAACGA TGCAGAAACA GTTTAAAACA AC -#GCAGATAC 60 - - ATTTCTGAAA CGATGCAGAA ACAGTTAGAT ACGGTGCTGC AGAAACAGTT GA -#AACGGTTC 120 - - AGAAACAGTT AGATACGGTG CTGCAGGAAC AGTTGAAACA ATGCAGAAAT AG -#TTGAGATA 180 - - CTGTGCTGCA GAAACAGTTG AAACGGTGCA GAAACAGTTG AGACACGGTG CT -#GCAGAAAC 240 - - AGTTGTAACG GTGCAGAAAC AGTTAGATAC GGTGCAGAAA TAATGAGATT CA -#ACGAGATA 300 - - CATTGAGGAT GGATGAGGAA AAGTGAAATT GGGAATAATG AGAGGAGTAA AA -#GTGAAATT 360 - - GGGAGGAAAT GGTGAGAGGA AAAGTGAAAT ATGGGGAAAT GGGAGAAGCA AA -#AATGATAG 420 - - TCGGGGAAAT ATAAAGAAGA ATGTAAGGGC TTGGTATGTT ATGGGAAAAT AT -#TGCTATGT 480 - - TTTTGCTATG TTTGCAATTA TCTTGTGTTT TCCTCTATAT AGGGTAATTT TA -#CTAAAATG 540 - - TTGCTATGTT TGGTAATTAA GCTCTAAAAC TTGTACTTTT ATGTAAAAAT TC -#CTCGAGAT 600 - - AGCTTACAAC AACATATCCA ATGATATTCC ACCAATTTGG AATTTGGGGA GG -#GTAAAATG 660 - - TACGCAGACC TTGCCTCCAC TAAAATAGAA AAGTTGTTTT CAAAAGATCC TC -#GTTTAAAG 720 - - AAAATATTTT TTAAAAAATA AATTTAAAAA TATTTTGAAA ACATATTTAA AG -#TAAAACAA 780 - - TGATGAAAGA CTGAGATTAA GATAGGTTGT TCTTTCAAAT TTTCCAATAA TA -#TCGGTCAT 840 - - GTGAAAGCAA TAAGCGTGAG TTCAAGATGA ATAGTGTAGT TGAAACATGT CA -#AGATGGTG 900 - - GGCTTCCTAA TCACTCGCGG TCATGTCTTT TTGCAGCCAA TTGCATATTG TT -#TAAACAGA 960 - - TTATAAATTA AGTAACATTT AACAACACAT TAATTACCTT ACTGAAGCTT GT -#AAACTACT 1020 - - TTTCCTCTTT GACAAATTAA G - # - # 1041 - - - - (2) INFORMATION FOR SEQ ID NO:5: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #5: - - AAAGAAACAT TTCGAAAGCA CCC - # - # 23 - - - - (2) INFORMATION FOR SEQ ID NO:6: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - # 6: - - AAATTCTTCG TCCAGCACCA AATGG - # - # 25 - - - - (2) INFORMATION FOR SEQ ID NO:7: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #7: - - ATGAATTCAA AGAAACATTT CGAAAGCACC C - # - # 31 - - - - (2) INFORMATION FOR SEQ ID NO:8: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 33 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #8: - - ATAAGCTTAA ATTCTTCGTC CAGCACCAAA TGG - # - # 33 - - - - (2) INFORMATION FOR SEQ ID NO:9: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #9: - - AACTAAAATC AAGACAAGTA GTAATCCACC - # - # 30 - - - - (2) INFORMATION FOR SEQ ID NO:10: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #10: - - GTTGCTTATT GCTAGGTAAC GAATACTTG - # - # 29 - - - - (2) INFORMATION FOR SEQ ID NO:11: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #11: - - ACTCCCCTGC CCTTAATTGG TAATTTACAT - # - # 30 - - - - (2) INFORMATION FOR SEQ ID NO:12: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #12: - - AACACTCTTG GTGCTCAACC CCATCAGTCC - # - # 30 - - - - (2) INFORMATION FOR SEQ ID NO:13: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #13: - - AACTCGAGGG TTACTATATA CCAAAAACAC - # - # 30 - - - - (2) INFORMATION FOR SEQ ID NO:14: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #14: - - AAACAAAGAT TGGAGCATAA TCGACC - # - # 26 - - - - (2) INFORMATION FOR SEQ ID NO:15: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #15: - - TAGTTCATTT TTCATTCATC GAGAGG - # - # 26 - - - - (2) INFORMATION FOR SEQ ID NO:16: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #16: - - TATACGCGAA ATAGGACTAG AAGATAATTG G - # - # 31 - - - - (2) INFORMATION FOR SEQ ID NO:17: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #17: - - AAACAGAAAA TCAATCGACT CCCTCCTGG - # - # 29__________________________________________________________________________

Claims

1. An isolated cytochrome P450 gene comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:1.

2. An isolated cytochrome P450 gene comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:3.

3. An isolated DNA which comprises a nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO. 4.